HONG KONG SAR - Media OutReach Newswire - 27 March 2025 - At today's press conference, members of the education expert panel on vitiligo, including Dr Johnny Chan Chun-yin, ...

A few days ago, millions around the world cheered when the US Food and Drug Administration (FDA) approved a treatment for vitiligo - a topical cream that can restore pigment with unprecedented ...

Recent network meta-analyses identified the relative outcomes of various vitiligo monotherapies on vitiligo at 6 months.

Turkey: A decade-long study from a tertiary care hospital highlights the effectiveness and safety of narrow-band ultraviolet ...

“Our FDA-approved melanocortin technology SCENESSE ® has helped patients with a rare light-intolerance disorder lead more normal lives and is now showing promise as a treatment for ...

The Pavilion also charts CLINUVEL’s 20-year journey towards developing and commercialising SCENESSE ®, the first and only treatment for the rare metabolic disease erythropoietic protoporphyria (EPP).